REQUEST A DEMO
Total
USD $0.00
Search more companies

Reprofertil Sas (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Diagnostic Imaging Centers | Other Ambulatory Health Care Services
Full name: Reprofertil Sas Profile Updated: January 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Reprofertil Sas is based in Colombia. The head office is in Neiva. It operates in the Ambulatory Health Care Services industry. It was incorporated on September 16, 2016. The company’s latest financial report indicates a net sales revenue increase of 40.53% in 2025. There was a total growth of 6.67% in Reprofertil Sas’s total assets over the same period. The net profit margin of Reprofertil Sas increased by 0.18% in 2025.

Headquarters
Calle 7 No. 10 - 46
Neiva; Huila;

Contact Details: Purchase the Reprofertil Sas report to view the information.

Basic Information
Registered Capital:
Purchase the Reprofertil Sas report to view the information.
Financial Auditors:
Purchase the Reprofertil Sas report to view the information.
Incorporation Date:
September 16, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Reprofertil Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
40.53%
Total Operating Revenue
40.53%
Operating Profit
41.54%
EBITDA
41.54%
Net Profit/Loss for the Period
43.09%
Total Assets
6.67%
Total Equity
22.55%
Operating Profit Margin
0.07%
Net Profit Margin
0.18%
Return on Equity (ROE)
1.75%
Quick Ratio
0.18%
Cash Ratio
-0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?